On February 23, 2026 Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, reported that company management will participate at multiple upcoming investor conferences:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
TD Cowen 46th Annual Health Care Conference
Date: Monday, March 2, 2026
Presentation Time: 3:50 p.m. ET / 12:50 p.m. PT
Leerink Partners 2026 Global Healthcare Conference
Date: Tuesday, March 10, 2026
Presentation Time: 10:00 a.m. ET / 7:00 a.m. PT
Barclays 28th Annual Global Healthcare Conference
Date: Wednesday, March 11, 2026
Presentation Time: 11:30 a.m. ET / 8:30 a.m. PT
Live webcasts of the presentations will be available under "Events & Presentations" in the Investors section of the Company’s website located at www.xencor.com. Replays of the events will be available on the Xencor website for at least 30 days following the presentations.
(Press release, Xencor, FEB 23, 2026, View Source [SID1234662863])